2026 JPMorgan Chase Healthcare Week: Focusing on Authorization Transactions and Pricing Policies

At the 2026 JPMorgan Healthcare Conference, discussions on authorization transactions and pricing policies have received attention. The focus of the discussion is on authorization transactions rather than large mergers and drug pricing policies, which may affect companies such as AbbVie, Novartis, Revolution Medicines, and Abivax.